Abstract
Wilson's disease in childhood has several characters distinct from those in adults. The progression of the disease tends to be rapid, hepatic manifestations are common, cerebral symptoms related to dystonia are predominant, and tremor is rare.
Forty-nine children with Wilson's disease under the age of 15 were treated with D-penicillamine for 2 to 15 years. None of the presymptomatic patients subsequently developed any symptoms of the disease. The results of treatment in patients who had exhibited only hepatic symptoms were also excellent. However, neurological manifestations associated with a history of jaundice or ascites responded less well to chelation. These observations clearly indicate that early diagnosis and treatment are extremely important to ensure normal lives for children with Wilson's disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arima, M., Komiya, K., Kamoshita, S., Mukai, N.: Clinical and pathological characteristics in Wilson's disease in cases under ten years of age. Paediat. Univ. Tokyo 9, 17–22 (1963)
Arima, M., Komiya, K., Fujisawa, A., Matsuoka, K.: Prevention of Wilson's disease in asymptomatic patients. Proc. Austral. Ass. Neurol. 5 (1), 197–201 (1968a)
Arima, M., Sano, I.: Genetic studies of Wilson's disease in Japan. In: Wilson's disease (D. Bergsma, I. H. Scheinberg, I. Sternlieb, eds.), pp. 54–59. New York: National Foundation 1968b
Arima, M., Komiya, K.: Prevention of Wilson's disease. A long-term follow-up. Pediat. Univ. Tokyo 18, 22–24 (1970)
Bearn, A. G.: A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration). Ann. Hum. Genet. 24, 33–43 (1960)
Deiss, A., Lynch, R. E., Lee, G. R., Cartwright, G. E.: Long-term therapy of Wilson's disease. Ann. Int. Med. 75, 57–65 (1971)
Denny-Brown, D.: Hepatolenticular degeneration (Wilson's disease). Two different components. New Engl. J. Med. 270, 1149–1156 (1964)
Lange, J.: Long-term treatment of Wilson's disease with D-penicillamine. In: Wilson's disease (D. Bergsma, I. H. Scheinberg, I. Sternlieb, eds.), pp. 130–133. New York: National Foundation 1968
Silverberg, M., Gellis, S. S.: The liver in juvenile Wilson's disease. Pediatrics 30, 402–413 (1962)
Schmid-Rüter, E., Feist, D., Wesch, H., Roßner, J. A., Schärer, K.: Präsymptomatischer Morbus Wilson. Dtsch. Med. Wschr. 98, 1698–1703 (1973)
Sternlieb, I., Scheinberg, I. H.: The diagnosis of Wilson's disease in asymptomatic patients. J.A.M.A. 183, 747–750 (1963)
Sternlieb, I., Scheinberg, I. H.: Prevention of Wilson's disease in asymptomatic patients. New Engl. J. Med. 278, 352–359 (1968)
Sternlieb, I.: Present status of diagnosis and prophylaxis of asymptomatic patients with Wilson's disease. In: Disease of the liver and biliary tract (C. M. Leevy, N. J. Newark, eds.), pp. 137–142. Bern:Karger 1976
Tu, J.-B., Blackwell, R. Q., Fresh, J. W., Watten, R. H.: Diagnosis and treatment studies of patients in asymptomatic stage. In: Wilson's disease (D. Bergsma, I. H. Scheinberg, I. Sternlieb, eds.), pp. 114–121. New York: National Foundation 1968
Walshe, J. M.: The physiology of copper in man and its relation to Wilson's disease. Brain 90, 149–176 (1967)
Walshe, J. M.: Some observations on the treatment of Wilson's disease with penicillamine (D. Bergsma, I. H. Scheinberg, I. Sternlieb, eds.), pp. 126–129. New York: National Foundation 1968
Author information
Authors and Affiliations
Additional information
Supported by the Grant for the Research of Nanbyo, Ministry of Education, Science & Culture
Rights and permissions
About this article
Cite this article
Arima, M., Takeshita, K., Yoshino, K. et al. Prognosis of Wilson's disease in childhood. Eur J Pediatr 126, 147–154 (1977). https://doi.org/10.1007/BF00442196
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00442196